Literature DB >> 12219789

Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery.

Peter J Wahab1, Jos W R Meijer, Chris J J Mulder.   

Abstract

To assess histologic recovery in response to gluten withdrawal in celiac disease, 158 patients seen in our hospital during a 15-year period underwent follow-up small intestine biopsies (SIBs) within 2 years after starting a gluten-free diet; further SIBs were done if villous atrophy was present. A modified Marsh classification was used (IIIA, partial villous atrophy; IIIB, subtotal villous atrophy; IIIC, total villous atrophy). Of patients with Marsh IIIA, IIIB, or IIIC lesions, histologic remission was seen in 65.0% within 2 years, 85.3% within 5 years, and 89.9% in long-term follow-up. Eleven patients (7.0%) with persisting (partial) villous atrophy had symptoms and signs of malabsorption and were considered to have refractory celiac disease; 5 of them developed an enteropathy-associated T-cell lymphoma. Children recovered up to 95% within 2 years and 100% in the long-term. Histologic recovery in celiac disease after starting a gluten-free diet takes time and is incomplete or absent in a substantial subgroup of patients (10.1% villous atrophy after 5 years). Systematic follow-up of patients with celiac disease and the malabsorption syndrome and secondary complications is needed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12219789     DOI: 10.1309/EVXT-851X-WHLC-RLX9

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  78 in total

Review 1.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

2.  Celiac disease: management of persistent symptoms in patients on a gluten-free diet.

Authors:  David H Dewar; Suzanne C Donnelly; Simon D McLaughlin; Matthew W Johnson; H Julia Ellis; Paul J Ciclitira
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

3.  Severe spruelike enteropathy associated with olmesartan.

Authors:  Alberto Rubio-Tapia; Margot L Herman; Jonas F Ludvigsson; Darlene G Kelly; Thomas F Mangan; Tsung-Teh Wu; Joseph A Murray
Journal:  Mayo Clin Proc       Date:  2012-06-22       Impact factor: 7.616

4.  Capsule endoscopy in nonresponsive celiac disease.

Authors:  David S Atlas; Alberto Rubio-Tapia; Carol T Van Dyke; Brian D Lahr; Joseph A Murray
Journal:  Gastrointest Endosc       Date:  2011-08-11       Impact factor: 9.427

Review 5.  Age-related differences in celiac disease: Specific characteristics of adult presentation.

Authors:  Santiago Vivas; Luis Vaquero; Laura Rodríguez-Martín; Alberto Caminero
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

6.  Exploring anthropometric and laboratory differences in children of varying ethnicities with celiac disease.

Authors:  Seema Rajani; Abeer Alzaben; Leanne Shirton; Rabindranath Persad; Hien Q Huynh; Diana R Mager; Justine M Turner
Journal:  Can J Gastroenterol Hepatol       Date:  2014 Jul-Aug

7.  Prevalence and demographic characteristics of celiac disease among blood donors in Ribeirão Preto, State of São Paulo, Brazil.

Authors:  Suzeidi Bernardo Castanheira Melo; Maria Inez Machado Fernandes; Luiz Cesar Peres; Luiz Ernesto Almeida Troncon; Livia Carvalho Galvão
Journal:  Dig Dis Sci       Date:  2006-06-07       Impact factor: 3.199

8.  Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant.

Authors:  Catherine Rongey; Ivana Micallef; Thomas Smyrk; Joseph Murray
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

Review 9.  A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies.

Authors:  Brian P McAllister; Emmanuelle Williams; Kofi Clarke
Journal:  Clin Rev Allergy Immunol       Date:  2019-10       Impact factor: 8.667

10.  Small bowel neoplasia in coeliac disease.

Authors:  S D Rampertab; K A Forde; P H R Green
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.